{"title":"Novel GLP-1 mimetics in diabetes: lixisenatide and albiglutide","authors":"Jason Seewoodhary BSc, MRCP, John Davies MD, FRCP","doi":"10.1002/fps.79","DOIUrl":null,"url":null,"abstract":"<p><b>Lixisenatide and albiglutide are glucagon-like peptide-1 (GLP-1) agonists in clinical development that are similar to exenatide and liraglutide. This review critically considers the emerging evidence on the pharmacology, efficacy, safety and potential roles these two agents may have in clinical practice.</b></p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"12 2","pages":"20-22"},"PeriodicalIF":0.0000,"publicationDate":"2011-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.79","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
Lixisenatide and albiglutide are glucagon-like peptide-1 (GLP-1) agonists in clinical development that are similar to exenatide and liraglutide. This review critically considers the emerging evidence on the pharmacology, efficacy, safety and potential roles these two agents may have in clinical practice.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
